1. Home
  2. KEQU vs CLNN Comparison

KEQU vs CLNN Comparison

Compare KEQU & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kewaunee Scientific Corporation

KEQU

Kewaunee Scientific Corporation

N/A

Current Price

$35.62

Market Cap

106.6M

Sector

Industrials

ML Signal

N/A

Logo Clene Inc.

CLNN

Clene Inc.

N/A

Current Price

$5.92

Market Cap

48.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KEQU
CLNN
Founded
1906
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
106.6M
48.4M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
KEQU
CLNN
Price
$35.62
$5.92
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$32.67
AVG Volume (30 Days)
2.1K
54.9K
Earning Date
06-08-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.86
N/A
Revenue
$138,558,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$82.05
P/E Ratio
$22.03
N/A
Revenue Growth
7.72
N/A
52 Week Low
$30.33
$2.28
52 Week High
$60.89
$13.50

Technical Indicators

Market Signals
Indicator
KEQU
CLNN
Relative Strength Index (RSI) 32.17 64.53
Support Level N/A $5.59
Resistance Level $41.84 $6.88
Average True Range (ATR) 1.39 0.44
MACD -0.66 0.11
Stochastic Oscillator 8.19 90.42

Price Performance

Historical Comparison
KEQU
CLNN

About KEQU Kewaunee Scientific Corporation

Kewaunee Scientific Corp is a designer and manufacturer of technical furniture products for industries investing in spaces where discovery occurs, typically in laboratories. It serves in end-use markets that are all commercial, Life sciences, pharma, education, government and military research, etc. The company operates through two segments: The domestic segment designs manufactures and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, laminate casework, flexible systems, and Others; The International segment provides facility design, engineering, construction, and project management from the planning stage through the testing and commissioning of laboratories. It generates the majority of its revenue from the Domestic business segment.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: